{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:52:14Z","timestamp":1791262334793,"version":"4.1.0"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T00:00:00Z","timestamp":1786406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100006396","name":"Alexion Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006396","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["atherosclerosis-journal.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.atherosclerosis.2026.121867","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:39:13Z","timestamp":1785944353000},"page":"121867","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Lipid profile in pediatric and adult patients with lysosomal acid lipase deficiency treated with sebelipase alfa: longitudinal evidence from the International LAL-D Registry"],"prefix":"10.1016","volume":"421","author":[{"given":"Don P.","family":"Wilson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"D'Antiga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Balwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Madeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf","family":"Bodamer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Abel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Auchterlonie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Balistreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilio","family":"Ros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121867_bib1","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1016\/j.jhep.2013.02.014","article-title":"Cholesteryl ester storage disease: review of the findings in 135 reported patients with an underdiagnosed disease","volume":"58","author":"Bernstein","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.atherosclerosis.2026.121867_bib2","series-title":"The online metabolic and molecular bases of inherited disease","article-title":"Lysosomal acid lipase deficiency: the continuous spectra of disease variants","author":"Grabowski","year":"2019"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121867_bib3","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency\u2014an under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121867_bib4","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.jhep.2018.09.028","article-title":"The global prevalence and genetic spectrum of lysosomal acid lipase deficiency: a rare condition that mimics NAFLD","volume":"70","author":"Carter","year":"2019","journal-title":"J Hepatol"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2026.121867_bib5","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.3390\/nu16244309","article-title":"Practical recommendations for the diagnosis and management of lysosomal acid lipase deficiency with a focus on Wolman disease","volume":"16","author":"de las Heras","year":"2024","journal-title":"Nutrients"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121867_bib6","article-title":"Update on lysosomal acid lipase deficiency: diagnosis, treatment and patient management","volume":"148","author":"Camarena","year":"2017","journal-title":"Med Cl\u00ednica"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121867_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/gim.2015.108","article-title":"Rapid progression and mortality of lysosomal acid lipase deficiency presenting in infants","volume":"18","author":"Jones","year":"2016","journal-title":"Genet Med"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121867_bib8","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13023-020-01577-4","article-title":"Long-term survival with sebelipase alfa enzyme replacement therapy in infants with rapidly progressive lysosomal acid lipase deficiency: final results from 2 open-label studies","volume":"16","author":"Vijay","year":"2021","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.atherosclerosis.2026.121867_bib9","article-title":"Lysosomal acid lipase deficiency: report of five cases across the age spectrum","volume":"2018","author":"Curiati","year":"2018","journal-title":"Case Rep Pediatr"},{"key":"10.1016\/j.atherosclerosis.2026.121867_bib10","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1111\/liv.15620","article-title":"Lysosomal acid lipase deficiency manifestations in children and adults: baseline data from an international registry","volume":"43","author":"Balwani","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/j.atherosclerosis.2026.121867_bib11","article-title":"Distinguishing lysosomal acid lipase deficiency from familial hypercholesterolemia","volume":"24","author":"Sheth","year":"2023","journal-title":"JACC Case Rep"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2026.121867_bib12","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/MOL.0b013e328361f6c6","article-title":"Lysosomal acid lipase A and the hypercholesterolaemic phenotype","volume":"24","author":"Fouchier","year":"2013","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/j.atherosclerosis.2026.121867_bib13","series-title":"Alexion Pharmaceuticals, Inc","year":"2024"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2026.121867_bib14","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2026.121867_bib15","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/MPG.0000000000003452","article-title":"Long-term sebelipase alfa treatment in children and adults with lysosomal acid lipase deficiency","volume":"74","author":"Burton","year":"2022","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2026.121867_bib16","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.jhep.2021.10.026","article-title":"Sebelipase alfa in children and adults with lysosomal acid lipase deficiency: final results of the ARISE study","volume":"76","author":"Burton","year":"2022","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2026.121867_bib17","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s13023-023-02719-0","article-title":"A systematic overview of rare disease patient registries: challenges in design, quality management, and maintenance","volume":"18","author":"Hageman","year":"2023","journal-title":"Orphanet J Rare Dis"},{"issue":"25","key":"10.1016\/j.atherosclerosis.2026.121867_bib18","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol","volume":"139","author":"Grundy","year":"2018","journal-title":"Circulation"},{"issue":"12","key":"10.1016\/j.atherosclerosis.2026.121867_bib19","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1001\/jamacardio.2021.3508","article-title":"Association between cumulative low-density lipoprotein cholesterol exposure during young adulthood and middle age and risk of cardiovascular events","volume":"6","author":"Zhang","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.atherosclerosis.2026.121867_bib20","first-page":"1","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. The task force for the management of dyslipidaemias of the European Society of cardiology (ESC) and European Atherosclerosis Society (EAS)","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.atherosclerosis.2026.121867_bib21","series-title":"Lysosomal acid lipase deficiency south dartmouth","author":"Wilson","year":"2023"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2026.121867_bib22","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3390\/nu18020233","article-title":"Best practices for the nutritional management of infantile-onset lysosomal acid lipase deficiency: a case-based discussion","volume":"18","author":"White","year":"2026","journal-title":"Nutrients"},{"key":"10.1016\/j.atherosclerosis.2026.121867_bib23","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.jpeds.2015.11.018","article-title":"Changes in fasting lipids during puberty","volume":"170","author":"Eissa","year":"2016","journal-title":"J Pediatr"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2026.121867_bib24","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.jacl.2018.05.011","article-title":"Pediatric lipid reference values in the general population: the Dutch lifelines cohort study","volume":"12","author":"Balder","year":"2018","journal-title":"J Clin Lipidol"},{"issue":"24","key":"10.1016\/j.atherosclerosis.2026.121867_bib25","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013225","article-title":"Diagnosis and treatment of heterozygous familial hypercholesterolemia","volume":"8","author":"McGowan","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"9","key":"10.1016\/j.atherosclerosis.2026.121867_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/liv.70279","article-title":"Sebelipase alfa improves aminotransferase levels in patients with lysosomal acid lipase deficiency: data from an international registry","volume":"45","author":"D'Antiga","year":"2025","journal-title":"Liver Int"}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915026012335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:17:26Z","timestamp":1791260246000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915026012335"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":26,"alternative-id":["S0021915026012335"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121867","relation":{},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipid profile in pediatric and adult patients with lysosomal acid lipase deficiency treated with sebelipase alfa: longitudinal evidence from the International LAL-D Registry","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2026.121867","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"121867"}}